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Abstract.  SEC2 function is required at the post-Golgi 
apparatus stage of the yeast secretory pathway. The 
SEC2 sequence encodes a protein product of 759 
amino acids containing an amino terminal region that 
is predicted to be in an c~-helical,  coiled-coil confor- 
mation. Two temperature-sensitive alleles, sec2-41  and 
sec2-59, encode proteins truncated by opal stop 
codons and are suppressible by an opal tRNA suppres- 
sor.  Deletion analysis indicates that removal of the 
carboxy terminal 251  amino acids has no apparent 
phenotype, while truncation of 368  amino acids causes 
temperature sensitivity. The amino terminal half of the 
protein, containing the putative coiled-coil domain, is 
essential at all temperatures.  Sec2 protein is found 
predominantly in the soluble fraction and displays a 
native molecular mass of >500 kD.  All phenotypes of 
the temperature-sensitive sec2 alleles are partially sup- 
pressed by duplication of the SEC4 gene, but the 
lethality of a sec2 disruption is not suppressed.  The 
sec2-41  mutation exhibits synthetic lethality with the 
same subset of the late acting sec mutants as does 
sec4-8 and secl5-1.  The Sec2 protein may function in 
conjunction with the Sec4 and Secl5 proteins to con- 
trol vesicular traffic. 
T 
RANSPORT of material from one organelle to another 
in eukaryotic cells is generally mediated by vesicular 
traffic (Palade, 1975).  The molecular events involved 
in the formation of vesicles from the donor compartment, 
their migration through the cytoplasm, and the recognition 
of and fusion with the target organelle are not yet under- 
stood. Both biochemical and genetic analysis have led to the 
identification of a number of components of the machinery 
(Novick and Schekman, 1979; Novick et al., 1980; Newman 
and Ferro-Novick, 1987; Segev et al., 1988; Wattenberg and 
Rothman, 1986; Block et al., 1988; Weidman et al., 1989). 
Since all vesicular transport events appear to share the same 
basic mechanism, some of these components may be required 
for all vesicular transport events.  Such a general role has 
been suggested for the product of the SEC18 gene (Wilson 
et al.,  1989). In addition to components that act generally, 
there must also be components that are required for only a 
single event or subset of events.  Components involved in 
regulating vesicle target recognition would be necessarily 
limited  in  their  range  of function.  Candidates for event- 
specific elements are the  10 SEC gene products that have 
been implicated in the final stage of the yeast secretory path- 
way (Novick et al.,  1980).  Defects in these genes block the 
pathway at the post-Golgi stage, but do not prevent transport 
from the endoplasmic reticulum to the Golgi apparatus or 
transport through the Golgi apparatus. 
One of the gene products specific for the post-Golgi ap- 
paratus stage is the GTP binding protein Sec4 (Salminen and 
Novick, 1987).  This protein appears to function in a cycle. 
It is synthesized as a soluble protein but rapidly associates 
with the cytoplasmic surface of secretory vesicles in a pro- 
cess that requires the carboxy terminal cysteines (Goud et 
al., 1988; Walworth et al., 1989). The vesicles fuse with the 
plasma membrane;  however,  Sec4  can reassociate with a 
new round of secretory vesicles. This cycle of localization 
may be obligatorily coupled to a cycle of binding and hydrol- 
ysis of GTP (Bourne, 1988; Walworth et al., 1989).  Strong 
genetic interactions have been seen between SEC4 and sev- 
eral other late acting SEC genes, including SEC2 and SEC15 
(Salminen and Novick,  1987).  Recent experiments suggest 
that Secl5 may function in response to Sec4 and Sec2 to dock 
secretory vesicles onto the plasma membrane (Salminen and 
Novick,  1989).  In this paper, we report the analysis of the 
SEC2 gene and its protein product. We present evidence that 
the Sec2 protein consists of two domains, an essential amino 
terminal domain that may contain a coiled-coil region and 
a dispensable carboxy terminal domain. 
Materials and Methods 
Yeast Strains and Genetic Techniques 
Table  I lists the yeast strains used for this study. All yeast cultures were 
grown either in rich medium (YPD) I containing 1% Bacto yeast extract, 
2 % Bacto peptone (Difco Laboratories Inc., Detroit, MI), and 2 % glucose 
or in minimal medium (SD) containing 0.7%  yeast nitrogen base without 
amino acids (Difco Laboratories Inc.), 2% glucose, and when necessary, 
1. Abbreviations usedin thispaper: ORE open reading frame; SD, minimal 
medium; YPD, rich medium. 
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NY  13 
NY  15 
NY  26 
NY  130 
NY  363 
NY 510 
NY  562 
NY  567 
NY 673 
NY 674 
NY 688 
NY 689 
NY  692 
NY  693 
NY  694 
NY  695 
NY  696 
NY 697 
NY  701 
NY  702 
MAT a, ura3-52 
MAT et, ura3-52, his4-619 
MAT a, ura3-52, sec2-59 
MAT a, ura3-52, sec2-41 
MAT a/c~, leu2-3, 112/+, ura3-52/ura3-52, his4-619~+ 
MAT c~  ura3-52, his4-619, sec2-41, GAL+ 
MAT ~  ura3-52, his4-619, sec2-41, SEC4::pNB229, (SEC4, URA3) 
MAT a  ura3-52, pNB134  (2u,SEC2,URA3) 
MAT c~  ura3-52, his4-619, sec2-70, SEC2::pNB289 (sec2-70,URA3) 
MAT c~  his4-619, ura3-52::pNB289 (sec2-70, URA3) 
MAT c~  ura3-52, his4-619, sec2-71, SEC2::pNB298 (sec2-71, URA3) 
MAT c~  his4-619, ura3-52::pNB298 (sec2-71, URA3) 
MAT a  ura3-52, sec2-59, pNB305  (Sup9e, URA3) 
MAT a  ura3-52, sec2-41, pNB305  (Sup9e, URA3) 
MAT a  ura3-52, sec2-59, pNB306  (SupS1, URA3) 
MAT a  ura3-52, sec 2-41, pNB306  (SupS1, URA3) 
MAT a  ura3-52, sec2-59, pNB307  (SUQ5, URA3) 
MAT a  ura3-52, sec2-41, pNB307 (SUQ5, URA3) 
MAT a/e~, leu2-3, 112/+, ura3-52/ura3-52, his4-619~+, SEC2::pNB298 (sec2-71, URA3) 
MAT a/eL, leu2-3, 112/+, ura3-52/ura3-52, his4-619~+, ura3-52:  :pNB298 (see2-71,URA3) 
supplemented for auxotrophic requirements, as described by Sherman et al. 
(1974). 
All yeast transformations were performed by the alkali  cation treatment 
method (Ito et al.,  1983).  Transformants were selected on SD medium at 
25°C, the only exception being NY15  transformants, for which SD sup- 
plemented with histidine was used as the selection medium, at 25°C. To ini- 
tiate  complementation assays,  yeast  transformants  were  grown  on  SD 
medium at 25°C for 3 d. Colonies were then replica stamped to YPD plates 
and incubated overnight at 37°C and 25°C, at which time colony growth 
was evaluated. Transformants exhibiting growth at the restrictive tempera- 
ture were streaked to single colonies on YPD plates at 37°C, and growth 
was compared to that of a wild-type strain at the same temperature. Sup- 
pression analysis also began with yeast transformants grown 3 d  at 25°C 
on SD medium. Transformants were then stamped onto YPD plates and 
grown overnight at 30, 36, and 37°C. The next morning, growth at the vari- 
ous temperatures was compared. Recovery of plasmids from yeast transfor- 
mants has been described earlier (Salminen and Novick,  1987).  Genetic 
crosses, the sporulation of  diploids, and dissection  of  tetrads were according 
to the methods described by Sherman et al.  (1974). 
Nucleic Acid Techniques 
The Escherichia coli strain DH1 (F-, recA1, endA1, gyrA96, thi-1, hsdR17, 
supE44,  redAl, lambda-) was used for all cloning experiments. Plasmid 
manipulations generally  followed procedures outlined by  Silhavy  et  al. 
(1984). 
Plasmid pNB70 was isolated by complementation from a yeast genomic 
library, described by Rose et al.  (1987),  generated by the introduction of 
wild-type yeast inserts into the single-copy shuttle vector YCp50  (yeast 
CEN4,  URA3; amp  R, tetR). The plasmid pNB132 was constructed by in- 
serting the 4.5 kb Cla I-Bam HI fragment from pNB70 into the Cla I and 
Bam HI sites of YCp50.  Insertion of this same 4.5-kb fragment into YIp5 
(Struhl et al.,  1979) and the 2u-based vector pRB307 (from the collection 
of D. Botstein) resulted in the integrating plasmid pNB133 and the high copy 
plasmid, pNB134  respectively. Construction of pNB313 required the dele- 
tion, from pNBI32, of the 1.73-kb Xba l-Bam HI fragment, arising from 
cleavage  at the internal Xba I site and the Bam HI site. Under conditions 
favoring partial Xba I digestion, pNBi32 was cut with Xba I and Bam HI, 
and the resulting mixture was treated with Klenow fragment (Boehringer 
Mannheim Diagnostics Inc., Houston, TX) to fill in the 3' recessed ends. 
Subsequent separation of  the fragments on a 0.5 % agarose gel permitted iso- 
lation of the plasmid lacking the 1.73 kb Xba l-Bam HI fragment by the 
phenol extraction method described by Benson (1984).  Blunt end ligation 
of the plasmid using T4 DNA Ligase (Boehringer Mannheim Diagnostics 
Inc.) regenerated the Bam HI site at the former Xba I site. 
Plasmid pNB209  contains TrpE  fused to  an  internal SEC2 fragment 
(185-1016 bp; amino acids 61-338). To generate pNB209, pATH1 (Dieck- 
man and Tzagaloff,  1985) was first digested with Sac I and the 3' overhang 
digested back to a blunt end with Klenow fragment. After phenol extrac- 
tion, the vector was cut with Bam H1 (both Sac I and Bam HI sites are lo- 
cated in the polylinker region of  pATHI), electrophoresed  on a0.8% agarose 
gel, and purified. To obtain the insert, the I.l-kb Pvu II-Bam HI fragment 
was isolated from pNB313 and digested with Dra I. The 83 l-bp Dra I-Bam 
HI fragment, after purification, was inserted, in frame, into the vector and 
ligated with T4 DNA ligase, blunt end at the Sac I-Dra I juncture, sticky 
end at the Bam HI-Bam HI juncture. 
For construction of the integrating plasmid pNB289,  the 3.3-kb  Pvu 
ll-Bam HI fragment from pNB132 was isolated and subsequently digested 
with Rsa I and Ava II. This mixture was then Klenow treated. The blunt- 
ended 897-bp Rsa I-Ava II fragment, purified from a 0.8% agarose gel, was 
ligated in to YIp5 cut with Cla I, treated with Klenow, and dephosphory- 
lated with calf intestinal alkaline phosphatase (Boehringer Mannheim Diag- 
nostics Inc.). Xba I and Bam HI digestion of the construction revealed the 
insert orientation. Construction of another integrating plasmid, pNB298, 
involved purification of the 1.97 kb Dra l-Dra I fragment of pNB132  after 
digestion with Cla I, Bam HI, and Dra I. Sau Ilia digestion of  this fragment 
yielded five subelones, the largest of which, an 865-bp Sau IIIA-Sau Ilia 
insert, isolated from a 1.0% agarose gel, was ligated into Ylp5 cut with Bam 
HI and treated with calf intestinal phosphatase. Insert orientation was deter- 
mined by digestion with Eco RI and Xba 1. 
Two alleles of SEC2, sec2-41 and sec2-59, were cloned on the plasmids 
pNB302 and pNB303,  respectively. Plasmid pNB132  was cut to completion 
with Xba I, these "gapped  ~ molecules were then repaired in vivo by chro- 
mosomal copies of the respective mutant yeast strains. Presence of the sec2 
locus on the recovered plasmids was determined by comparison of P~u II 
and Xba I restriction patterns with those of pNBI32 and subsequently by 
DNA sequence analysis. 
Three suppressor tRNA genes were generously donated by Dr. lan Willis 
and Dr. Dieter $611 (the Molecular Biophysics and Biochemistry Depart- 
ment, Yale University).  All three plasmids have been renamed for this study: 
pNB305 contains the opal suppressor sup9e (Willis et al.,  1984),  pNB306 
carries the amber suppressor supS1 (Krupp et al.,  1985), and pNB307 car- 
ries the ochre suppressor SUQ5 (Olson et al.,  1981). YCp50 served as the 
parent vector for all three constructions. 
DNA Sequencing Strategy 
Nucleotide sequencing was performed using the dideoxy chain termination 
method devised by Sanger et al.  (1977),  in the presence of [a-35S]dATP 
(650 Ci/mmol; Amersham Corp., Arlington Heights, IL) (Williams et al., 
1986).  Sequencing reactions were electrophoresed on 8 % acrylamide gels 
(40:1.3%  acrylamide/bis) containing 8  M  urea.  DNA templates for se- 
quencing contain restriction fragments of the 4.5-kb Cla I-Barn HI insert 
of pNB132  subcloned into the M13 phage derivatives mpl8 and mpl9 and 
were used  in combination with a  [-20]  17-mer  Sequencing Primer (No. 
1211; New England Biolabs, Beverly,  MA) or one of three 17-mer primers 
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the sec2-59 allele, restriction fragments ofpNB303 subcioned into Ml3mpl8 
and mpl9 served as template DNA. 
Protein Sequence Homology and Secondary 
Structure Analysis 
The homology search conducted compared the predicted See2 protein with 
the National Biomedical Research Foundation library using the FASTP pro- 
gram in the ktup-2 mode (Lipman and Pearson, 1985). Secondary structure 
analysis of the See2 protein used the Chou and Fasman parameters (Chou 
and Fasman, 1978) and was plotted using the PLOTSTRUCTURE program 
of the University of Wisconsin Genetics Computer Group (UWGCG)  package. 
Preparation of TrpE-SEC2 Fusion and 
Rabbit Immunization 
Production of fusion protein was induced in the E.  coli strain, NRB209, a 
DHI transformant containing the pNB209 plasmid, as described by Goud 
et al.  (1988).  A  20-ml culture was harvested at 4,000  rpm for  10 min, 
washed in 25 mM Tris (pH 8.0), and resuspended in i.0 ml of 10 mM NaPi 
(pH 7.2),  !%  2-mereaptoethanol,  1%  SDS, 6  M  Urea, and incubated at 
37°C for 30 min. The sample was then transferred to a  1.5-ml  microfuge 
tube and spun at  13,000  rpin at 4°C for 20 rain to remove~nucleic acids. 
The supernatant was collected in a fresh tube and Bromophenol Blue added 
to a  final  concentration of 0.05%.  Electrophoresis on a preparative SDS 
polyacrylamide gel separated the proteins in the whole cell lysate and per- 
mitted the excision of  the fusion protein band, after staining with Coomassie 
brilliant blue. The gel band was cut into pieces, destained, soaked in dis- 
tilled  water  for  2  h,  and  stored  at  -20°C.  Fusion  protein  gel  slices 
homogenized in 0.5 ml of PBS and an equal volume of Freund's Complete 
Adjuvant was administered to anesthetized rabbits subcutaneously for the 
primary injection. All subsequent boosts were also subcutaneous, at  l-mo 
intervals,  using fusion gel cubes homogenized in PBS alone. The acryl- 
amide serves as an efficient adjuvant. 
For affinity purification of anti-Sec2 antibodies, the TrpE-Sec2 fusion 
protein was collected from gel slices by electroelution (Hunkapillar et al., 
1983)  in  SDS-PAGE buffer at  100  V  overnight  (Laemmli,  1970)  and 
precipitated  using  an  acetone-triethylamine-acetic  acid-water  mixture 
(Konigsberg and  Henderson,  1983).  Fusion protein was then covalently 
bound  to  glutaraldehyde-activated  polyacrylamide  beads  (Act-UItrogel 
ACA 22;  LKB Instruments Inc., Gaithersburg, MD) and affinity purifica- 
tion proceeded as described by Goud et al. (1988).  For 3 h at room tempera- 
ture,  5.0  ml  of rabbit  serum  was circulated through the  fusion protein 
column; antibodies were eluted from the column according to Guesdon and 
Avrameas (1976). 
Electrophoresis  and Immunoblotting 
Protein samples for SDS-PAGE were heated for 5 min at  IO0°C  in sample 
buffer and run on 1.0-mm-thick 10% gels as described by Laemmli (1970). 
Transfer of proteins to nitrocellulose (BA 83; 0.22 #m, Schleicher & Schuell 
Inc,, Keene, NH) proceeded at 250 mA at 4°C overnight. Probing of blots 
with affinity-purified anti-SEC2 antibody and radio-iodinated 1251-protein 
A (0.5 p.Ci/ml; 30 mCi/mg, Amersham Corp.) was accomplished using the 
basic procedures described by Burnette (1981) and Goud et al. (1988).  Blots 
were blocked for 15 min in TBS buffer (10 mM Tris,  150 mM NaCI, pH 
7.5)  containing  1%  gelatin (Eastman Kodak Corp.,  Rochester, NY)  and 
0.5% BSA, then for 15 min in the same buffer containing 0.1% Tween-20 
(blocking  buffer).  Into this blocking buffer the anti-See2  antibody was 
diluted 1:200  and incubated with the blots for at least 2  h. After four 10 
min washes in TBS-Tween, blots were incubated for 2 h with ~25I-protein 
A in blocking buffer.  All incubations occurred at room temperature. Blots 
were dried after four  10 rain washes and autoradiographed for 3-16 h. 
Preparation  of Protein Samples and Measurement of 
Protein Concentrations 
Yeast cultures were grown in YPD or SD medium to an A600 of 0.6. Cells 
(30 A600 U) were pelleted in a clinical centrifuge, washed, and resuspend- 
ed in 10 mM Tris (pH 7.5), containing a mixture of protease inhibitors and 
then broken with glass beads by continuous vortexing for 3 min at 4°C. A 
small aliquot was removed for determination of  protein concentration as de- 
scribed by  Walworth and  Novick  (1987).  The  remaining portion of the 
whole cell lysate was boiled for 5  min in sample buffer.  Cooled to room 
temperature, the lysates were then transferred to microfuge tubes and spun 
l min; the supernatants were removed to fresh tubes and stored at -20°C. 
Measurement of  lnvertase Secretion 
Procedures for determination of invertase secretion have  been described 
previously (Goud et al., 1988). Cells were grown overnight in YPD at 250C. 
Approximately 1.5  x  107 cells were sedimented in a  clinical centrifuge 
and resuspended in 2.0 ml ofYP +  0.1% glucose. Half of each sample was 
pelleted immediately, resuspended in l0 mM NAN3, and stored at 0°C; the 
other 1.0 ml of cells was incubated at 37°C (Table III) or 34°C (Table IV) 
for l  h, then harvested, and resuspended in NaN3 at 0°C. Spheroplast ly- 
sates were prepared by the addition of 0.5 ml of cell suspension to 0.5 ml 
of a  solution containing 2.8  M  sorbitol, 50  mM  Tris (pH 7.5),  l0 mM 
NAN3, 50  mM 2-mereaptoethanol, and 0.05  mg/ml zymolyase 100T and 
subsequently  incubated  at  37°C  for  40  min,  after  which the  resulting 
spheroplasts were sedimented and lysed in 0.5  ml of 0.1%  Triton X-100. 
Methods of assaying invertase have been described earlier (Goldstein and 
Lampen,  1975). 
Results 
Cloning of the SEC2 Gene 
The SEC2 gene was cloned from a plasmid library contain- 
ing yeast genomic DNA inserts in the YCpS0 shuttle vector 
(Rose et al.,  1987). The plasmid pNB70 (Table II, Fig.  1 A) 
was identified by its ability to complement the temperature- 
dependent lethality of the haploid strain  NY130 (sec2-41, 
ura3-52). Initial restriction analysis followed by a  series of 
deletions identified the 4.5-kb Cla I-Bam HI fragment, con- 
tained on the plasmid pNB132,  as a  fully complementing 
subclone (Fig.  l  A).  More extensive mapping lead to esti- 
mates of the specific location of the complementing region 
on the Cla I±Bam HI fragment. When the 1.4-kb Cla I-Pvu 
II fragment was deleted and the resulting construction intro- 
duced into NY130, transformants grew at the restrictive tem- 
perature (37°C). However, when transformants were streak- 
ed to single colonies at 37°C, growth was found to be severely 
limited (data not shown). The plasmid pNB313, created by 
deletion of the 2.1-kb segment extending from the middle 
Xba I  site to the Bam HI site and  leaving a  2.38-kb  Cla 
I-Bam HI fragment (the Bam HI site was regenerated at the 
Xba I site), did not complement the sec2-41 defect. The plas- 
mid pNB316 containing a 3-kb insert consisting of the two 
Xba I fragments gave complete complementation upon in- 
troduction into NY  130 (Fig.  1 A). These data suggest that 
the SEC2 gene lies between the two outer Xba I sites.  The 
middle Xba I site is most probably located within the coding 
region of the $EC2 gene, while the Pvu II site may cut near 
an end of the gene. 
To confirm the identity of the complementing region,  it 
was necessary to prove that this genomic fragment could di- 
rect integration of a linked marker gene, URA3 in this case, 
into the SEC2 gene locus. The plasmid pNB133, constructed 
by insertion of the 4.5-kb Cla I-Bam HI fragment into the 
YIp5  integrating plasmid,  was cut with Xba I and used to 
transform the wild-type yeast strain NYI5 (ura3-52, his-619) 
to Ura  +. A gene duplication results by homologous integra- 
tion at the locus corresponding to that of the insert, with the 
URA3 marker between the two copies (Fig.  1 C, top line) 
(Orr-Weaver et al.,  1981).  The resulting strain,  carrying a 
duplication of the insert gene, was crossed to NY130 (ura3- 
52, sec2-41 ). When tetrads were analyzed, tight linkage of 
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pNB70 
pNB132 
pNB133 
pNBI34 
pNB209 
pNB289 
pNB298 
pNB302 
pNB303 
pNB305 
pNB306 
pNB307 
pNB313 
pNB316 
pNB318 
YCp50, SEC2; ll-kb genomic insert in the Bam HI site 
YCp50, SEC2; 4.5-kb Cla I-Bam HI fragment from pNB70 into Cla I-Bam HI sites 
YIp5, SEC2; 4.5-kb Cla I-Bam HI fragment from pNB70 into Cla I-Barn HI sites 
21~, SEC2; 4.5-kb Cla I-Bam HI fragment from pNB70 into Cla I-Bam HI sites of the vector pRB307 
pATH1, TrpE-SEC2 fusion; .84-kb Dra I-Bam HI(Xba I) fragment from pNB313 into Sac I (Klenow-treated) and 
Barn HI sites of pATH1 
YIp5, SEC2; internal 0.9-kb Rsa I-Ava II fragment (blunt) from pNB132 into the Cla I (blunt) site 
YIp5, SEC2; internal 0.86-kb Sau HI A-Sau HI A fragment from pNB132 into the Bam HI site 
YCp50, sec2-41; pNB132 was gapped with Xba I and introduced into NY 130, then reisolated after plasmid repair 
at the sec2-41 chromosomal locus 
YCp50, sec2-59; pNBI32 was gapped with Xba I and introduced into NY 26, then reisolated after plasmid repair 
at the sec2-59 chromosomal locus 
YCp50, sup9e; 1.55-kb Cla I-Eco RI fragment from a YRpl7  clone (opal, sup9e) into Cla I-Eco RI sites 
YCp50, supS1; .44-kb Hin D IlI-Barn HI fragment from YRp51 clone (amber, supS1) into Hin D III-Bam HI sites 
YCp50, SUQS; 1.1-kb Hin D III-Bam HI fragment (ochre, SUQ5) into Hin D III-Bam HI sites 
YCp50, SEC2; 2.28-kb Cla I-Bam HI fragment, Xba I (internal)-Bam HI of pNB132, Barn HI site regenerated 
at Xba I site 
YCp50, SEC2; 3.0-kb Xba I-Xba I fragment cloned into Xba I site of pUC19 and from there into the Hind III and 
Barn HI sites of YCp50 
pBR322, SEC4, LEU2; 1.4-kb SEC4 fragment inserted into the Eco RI and Bam HI sites and the LEU2 gene 
inserted into the Sal I site 
the site of integration with the SEC2 locus was established: 
all  tetrads  consisted  of  two  Ura  ÷,  temperature-resistant 
spores and two Ura-,  temperature-sensitive spores.  These 
data strongly suggest that the cloned sequence contains the 
SEC2 gene. Definitive proof was obtained by sequence anal- 
ysis of the sec2-59 mutant allele as described below. 
SEC2 Encodes a Hydrophilic Protein Containing a 
Possible Coiled-coil Domain 
Based  on  the  localization  estimates  discussed  above,  se- 
quence analysis of the 4.5-kb Cla I-Barn HI clone was be- 
gun, focusing on the region downstream of the Pvu II site. 
In total,  the 3-kb complementing region between the outer 
Xba I sites was sequenced, within which a single long open 
reading frame (ORF) of 2,280 bp was revealed (Figs. 1 B and 
2).  This  ORF  encodes  a  putative  protein  product  of 759 
amino acids with a predicted molecular mass of 84 kD. The 
See2 protein is quite hydrophilic, 32 % of the amino acids be- 
ing charged, 15 % basic and 17 % acidic. Based on hydropho- 
bicity analysis, there are no stretches of sufficient length and 
hydrophobicity to constitute a membrane spanning region. 
The See2 protein sequence was compared with proteins in 
the PIR database. The amino terminal 200-300 amino acids 
of the See2 protein display significant similarity to the c~-he- 
lical,  coiled-coil  portions  of four  myosins and  to  several 
other cytoskeletal proteins,  including  a  Type II keratin,  a 
troponin,  and a tropomyosin, the  identity ranging from 20 
to 26%. In the case of the cardiac myosin ct heavy chain, the 
24.6%  identity with the Sec2 protein over 167 amino acids 
involves the $2, rod portion of the cytoskeletal protein (Fig. 
3 A) (Kavinsky et al.,  1984). This domain of myosins serves 
a vital function in the formation and assembly of thick fila- 
ments in skeletal muscle and follows a strict 7-residue amino 
acid  repeat pattern,  characteristic  of a-helical  coiled-coil 
proteins, in which hydrophobic amino acids are found exclu- 
sively at two positions of the or-helix forming a hydrophobic 
stripe along which two similar chains may interact (Crick, 
1952).  Secondary  structure  analysis  using  methods  de- 
scribed  by  Chou  and  Fasman  (1978)  and  Gamier  et  al. 
(1978) both predict a strong c~-helical nature for the first 300 
amino acids of Sec2 (not shown). Over the region from resi- 
due 50 to 106 the sequence closely matches the heptad repeat 
rules (Fig.  3 B).  With only 3 exceptions, positions 3 and 6 
are occupied by hydrophobic amino acids. Another common 
feature of coiled-coil proteins is the presence of frequent salt 
bridges stabilizing the c~ helix (Sundaralingam et al.,  1987; 
Marqusee  and Baldwin,  1987).  In this region of the  Sec2 
protein, there are 15 predicted salt bridges between adjacent 
residues of the helix (Fig. 3 B).  An unusual feature of Sec2 
is that position 2  is occupied by acidic residues in 6 out of 
8 repeats. The significance of this is unclear. On either side 
of this eight heptad repeat region lie regions of similar size 
that fit the heptad repeat rules somewhat more loosely and 
are shifted in frame with respect to the 50-106 region. In the 
region from residue 1 to 49 two adjacent positions of the he- 
lical wheel are occupied by hydrophobic residues in 10 of 14 
cases. While in the region from 107 to 162, two adjacent po- 
sitions  of the  helical  wheel  are  occupied  by  hydrophobic 
residues in  13 of 16 cases. The carboxy terminal half of the 
protein does not exhibit any striking homologies; however, 
it is quite hydrophilic and includes a  region (residues 542- 
650)  that is 37%  serine or threonine. 
Production of  Anti-Sec2 Antibodies 
We raised,  in  rabbits,  polyclonal antisera against a  fusion 
protein comprised of the TrpE protein and a portion of the 
SEC2 gene,product (amino acids No. 61-338) (see Materials 
and Methods). Although the SEC2 sequence predicts a pep- 
tide of 84 kD, on immunoblots (Fig. 4) the antisera recog- 
nizes  a  band  in  wild-type  (NYI5)  whole  cell  lysates that 
migrates at 105 kD. To verify the identity of the 105-kD im- 
munoreactive band as the SEC2 gene product,  the 4.5  Cla 
I-Bam HI fragment was inserted into a high copy number, 
2#-based vector and the resulting plasmid, pNB134, was in- 
troduced into a wild-type strain. Transformants were selected 
on minimal media (SD). On immunobiots, whole cell lysates 
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Figure 1.  Genetic analysis of 
the SEC2 locus.  (A) Comple- 
mentation  of sec2-41 by  the 
various  subclones  described 
in  the  text  and  in  Table  II. 
ORF,  heavy arrows.  (B)  Re- 
striction map and sequencing 
strategy  of SEC2. The  start 
and stop codons are indicated 
as are various mutations.  (C) 
Various  alleles  generated  by 
integration.  The top line shows 
the integration of pNB133 into 
the genome, generating a du- 
plication.  The  sec2-70 allele 
was  constructed  by  integra- 
tion of PNB289  into the  ge- 
nome. The sec2-71 allele was 
generated  by  integration  of 
pNB298.  This allele yields a 
temperature-sensitive  pheno- 
type.  The sec2-72 allele  was 
constructed by replacement of 
the  Pvu  II-Nsi  I  region  of 
SEC2 with the URA3  gene. A, 
Alul; B, Bam HI; C, Cla I; D, 
Dra I; N, Nsi I; P, Pvu II; R, 
Rsa I; S,  Sau Ilia; X,  Xba I. 
of this overproducer (NY567)  show an '~10-fold increase in 
levels of the  same  105-kD  band  seen  in  wild-type  lysates. 
The  105-kD  band  is  absent  in  lysates of two temperature- 
sensitive sec2 mutant strains, sec2-41  and sec2-59 (Fig.  4); 
however, new bands appear at much lower apparent molecu- 
lar mass:  a 43-kD band in NY130  (sec2-4t, ura3-52) and a 
41-kD band in NY26 (sec2-59, ura3-52).  Together these data 
establish the 105-kD protein as the normal SEC2 gene prod- 
uct.  The surprising finding was the greatly increased mobil- 
ity of the Sec2 protein encoded by the temperature-sensitive 
alleles. 
Additional  bands observed in wild-type lysates and over- 
produced in NY567, but not seen in the mutants are probably 
Sec2 degradation products.  Low molecular mass bands, be- 
low those  of the mutants,  are present at equal  levels  in all 
samples regardless of variations in Sec2 protein content and, 
therefore,  most  likely  represent  nonspecific  binding  of the 
antibody. 
An Opal Suppressor tRNA Suppresses the sec2-41 and 
sec2-59 Defects 
There are  several possible explanations  for the  greatly  re- 
duced molecular mass of the mutant proteins.  The sec2-41 
and sec2-59 alleles could encode full length, missense pro- 
teins  that are sensitive to proteolytic  degradation  either  in 
Nair et al. Sec2 Protein  1901 -51~  TCT~6AAAAAT~GA66~CC6CAA~AAA~A~CCA~A66T~8CTA8CACA66TAAC~8CTAA~TTTCAAATAAAATATTAAA~CAAAAAATTAT~ACAACA6TAATACCAAAACAAA 
-39~  CATC~AAACAA6CA~TA6TACAAA8AAATA6TC~C6AATCATTAA~ICACATATATATAT~TAATTTTAAT6TTTATA~ATCACTTAT~ATACACTTTACATICATCTTTACT~AAAT8A 
-27~  TCTCTACTATT6CATTTTT•AAATAATTCCTTTTATTAT6T6CCATTGTTTCCATGT6ACTACCC•6AACTT•TATTTCGC•TTC6CT•AA6CACCTTTAAAACATG•CTCTC•TTTACC 
-15~  TAA6T•ACAA•CACA•T6ATTCGT8CAATAATATCATTT•TCACTT•CA•CT•TA•CAAC•TT6ATTTCCATCCAAAAGTT6TA•AAAATTTT•ACCTTTA6TTCACT•66ATATATTTT 
~etA~pA~a~er6~u~uA~aLysArgVa~er~e~nVa~Thr~erLeuSerThr6~nLeu~e6~uSerVa~AspLys6~nSer 
~  CCTTTACTA6CT•T•TTT6ATA•A••TTTCAATAT•6AT6CTTCT6A6•AA•CAAAAAGA6TATCAATACA••TTACATCCCTGTCTACGCAATT6ATC8AGA6C6TG•AT•AACA•TCA 
HisLeu6~u~u6~nLeu~snLysserLeuLy~Thr~eA~aSer6~nLy5A~aA~a~e6~uA~nTyrAsn~nLeuLy~6~uAspTyrAsnThrLeuLy~Arg~uLeu~er~spArg 
88  CACTTA~AA6AACA6CTTAATAAATCCTTAAAAACAATA6CCA6CCA6AA66CA6CAATTGAAAACTATA~TCA6TT~AAA6AA6ATTACAACACTTTAAAAA6A6AATT~TCA6ACA6A 
AspAsp6~uVa~Ly~ArgLeuArg6~uAsp~eA~aLysG~uAsn6~uLeuArgThrLysA~a6~u6~u6~uA~aAspLysLeuAsnLys6~uVa~6~u~spLeuThrA~a~erLeuPhe 
208  6AT8AC~AA6T6AAAA6MT~C6T6AA~ATATA~CCAAA~AAAAT6A~CTTCGAACTAAA~CT8AA6A~6AA8C~8ATAAACTAAATAAA8AA~TT6A66ATCT~ACT~CTTCCCTCTTT 
Asp6~uA~aAsnAsnMetVa~A~a~pA~aArgLy~uLysTyrA~a~eG~u~eLeuAsnLy~ArgLeuThr6iu~lnL~r9~uLysA~pThrLeuLeuAspThrLeuThrLeu 
528  ~Af8A~6C~AA~AA~A~T~CT6A~8~A~AAA~A6AAA~A~CTATC8AAA~CTTAAA~AA6A~ACTCA~T6AACAAC~C~6AAAA~6ACACA~A~T~8A~ACT~ACCC~A 
6~nLeuLysAsnLeuLysLysVa~NetHisSerLeuAspAsnG~uSerThrVa~ThrAsnAsnSer~snArgTyr8erThr~eLeuSerAspserA~aThr~er~erSerThr~erLeu 
448  CA•CTCAA•AATCT•AAAAAAGT6AT•CATAGTTTA•ATAAT•AAA••ACA6TCACAAATAATTCGAACA6ATATTCCACAATATT•A6T6ATTCA6CAACTTCTTCTA6CACTTCTTT• 
AsnLysvalPr~ThrSerTyrSerLeu~aSerG~nAsp~eTyrSer6~y~eV~Tyr~erPr~Ser~eSerSer~eArgTyrAsp~eSerLeuTyrAsn6~uPheLeuLysPhe 
5~8  ~ATAAAGTTCCAACTTCATATTCTCTT6CTTC~CAA6ATATTTATA6C6~AA~TGT6TA~TCGCCAA~CATTTCATCTATTC~TTATGATATAA6CCTTTACAAT6AATTTCTAAAATTT 
Va•A•aA•aLeuPr•ArgCysG•uAsn••eLysA•aThrSerThr6•u•erLysLeu•leArgArgLeuVa•AsnAspG•u••e6•nPr•••eLeuLys••eAspAsnA•aSer6•y••e 
~88  6TC~CT~CACTACCCC~TT~T6~AAACATAAA66CAACTTCAACC~ATCAAA8TTAATAC~AA~ATT6~TAAAT~AT6A~ATCCA~CC~ATAC~TAA~ATT6ATAAT6CTTCA6~CATC 
6•yTrpLeuVa•LysLysThrLeuLeuserLeu••e••eAsp••yLeuVa•Va•Va•6•uPr•Leuser6•yVa•AsnA•aThrTyr6•n••e6•yTyrAsnserSerSerPr•A•aLys 
808  ~CT~GTT~6TTAAAAAAACCCTACTTTCCTT~ATTATA6ATGGTTT~GT~TC~T~6AACCCCTAA~C~C6TTAAT~CAACCTACCAAATTG~CTACAACTCAA6TA6CCCT~CAAA~ 
G~nA~aThrSerAsnHetPr~Ly~HetPheLysPhePr~LeuAspSerPr~Pr~Va~A~aVa~HisA~aA~aCys~er~heCys6~y6~u~erArgAspAsp~e~e6~uHis~a~rg 
928  CAAGCCACTTC6AATAT~CCAAAAAT6TTCAAGTTTCC~TTA~ATTCACCTCCA~TT~CA~T6CAC~CCGCAT~TTCCTTTT~T6~A~AATCTA~A~AT~ACATTATC~AACAC~CAA~G 
HetTyr~eLeuLy~ThrLeuHisLysThrAsp~spG~yLys6~u6~nVa~ThrAsnThrTyrPr~LeuCysHisTrpCysLeuLeuLysLeu~rg6~nThrCysG~u~ePhe~aPhe 
1048  ATGTATATATT~AAAAC~TT~CACAA6ACT~AC~ACG6TAAA~AACAA6TTAC~AATACGTATCCCTT8T~TCATTG~T~TTTGCTAAA~TT~CGGCAGACAT~T~AAATCTTT~CTTTC 
LeuArg8erLeuLysva~6~y~aTrpHisLeu6~uLysLeuThrThrG~nAsn~eThrLysG~uAspLeu~uLys~heSer6~uVa~ThrLysHisThrLysArgAsp6~y~rgVa~ 
llb8 CTGA~AT~ATT~AA~T~6~C8CAT~GCA~TTA~AAA~GCT~AC~A~CA~AAC~TTACCA~AA6ATTT~8AAAAATTCTCT6AAGTAAC6AA6CATACCAAAA6A6AC~6CA~TT 
ser~erG~nAspLysLysThrLysArgLeuSerPheMet~aG~yLeuG~y~eAsnserSerThrLysAsnLysPr~LysMet6~u~ePheSerSerG~uThrAsnA~aLysPr~G~y 
1288  T~TTCTCAA~ACAAAA~ACCAA~C~TTTAA~TTTTAT~6C~66ACTTG~T~TCA~TTCTTC~CAA~A~A~AA~CCAAA~AT~6A8~TTTTTTCTTCT~ACAAAT6C~AA6CC~66A 
6~nPr~ThrThrAsn~e~nArgA~aTrpLeu~nLeucysLysLeuArgCys~eLeuHisTrpThrHis~e6~y~eTrpA~aVa~sp~spSer~eSerSerLys~e6~yPr~ 
1408  CAACCTACCACTAATATTCAAA~A~CAT~CT6CAATT~T~TAAATT~C~TT~TATACTTCATTG~ACTCATATTG~CAT~T~CAGT~AT~TTCAATTTCTTCAAAAATTG~A~C~ 
LeuVa~6~uAspAspSerAsp~uAsp6~nAsnAsp~a~eSerVa~ArgLeu6~nAspLysA~aLeuTrpLys~nAspA~aLysArgPr~PheSerSer~erSerA~a6~u6~uSer 
1528  TTAGTT6A~ATGACA8CGAT~A6~ATCAAAAC~ATGCTMATCGGTTC8CTTGCA6GACAAA6CTCTTTGGAA~CA6GAC6CAAAAAGACCTTTTTCTTCATCTA6C6CA~AA6AAAGT 
G~nLysSerAspA~aPhe~spPhe6~uSer~yAspMeL~uAsn6~u~eThr~yG~uSerSerSer~spG~u~erSerserAsp6~ySerSerThrAsp~sn~erThrA~aAspSer 
I~48 CAAAA~A~C~AC8CTTTT~AC~TT8AAA~T~AGATAT~AAAA~AAATTA~T6AA~CT~CAA~TGAT~AATCC~CT~CA~A~G~T~CACA~A~AA~TCAACC~A6ATA~ 
SerSer6~uAspG~u~erSerLeuA~aAspSerThrThrSerSerA~aAspSerSerSerPr~8~uSer~eAsp~snG~y6~u6~yAspAspThrva~ThrLys~spAspLysSer8er 
17~8  T~AT~A~AA~ATGAATCTT~T~TAG~A8ATT~TA~TA~AA6TA~CA6ATTCTAGTT~A~AGA~AGTATA6ACAA~GGT6AA6GTGATGA~A~8GTAACGAAA~AT8AcAAAAGT~GC 
~eLysSerA~aAsnAsn~sn6~u~uAsnSer~spCys6~y~spLysLysG~yArgSer~e~eLysLysLysA~aPr~6~nArgLys~e6~nLysLysLysLeuLeuG~nAspLeu 
1888  ~TTAAG~CG~CAAATAATAAT~AA8AAAAC~8C~A~T~C8~A6MAAAAAA6~C~CTA~AA~AAA~AAAAA~6C~CCIC~AC8CAAGATAC~AAA6AA~AAGT~ACTCCAA6A~ 
~spAspLeu~u~u6~nPheArg~u6~u~er~a~e~sp6~nThrG~upheG~u~snA~aG~uSerAsnVa~Lys6~nAsn~eSer~erLysArg~aSer~er6~yA~p6~u~n 
2008  6AT8ATTTA6AA8A6CAATTTA6A6AA~AAA6C6C~ATT6ATCA6ACT~AAT~T~AA~AC~CT6A6TcTAAT6TAAAACAAAATMAT~C~C6AA6A666cMCTTCT66A~A~6A~AAC 
SerLysLys~spAsn~sn~uLysThrLeuLysThrAsnLeuIhrI~e6~yAspLysThr6~n6~uGln~e6~yG~u~snSerPr~ser~erG~yLeuHisA~aSerSerSerAsnAsp 
2128  ~T~AA~ATAATAA~AAAAAAcT~TAAA8A~A~AC~8A~MA~G~8A~AAAC~AA~AACAAA~A6~AAAATA6TC~T~6T~G~6~M~G~T8~8T~AA~M~M 
AspAsnPheAspAspAlaGlnGluGlnGln|l| 
2248  ~CAATT~C8ATGA~CCCA6~AACA8CAA~AAA~TA~ATAA~ATT~AAT~AT6~C~AM6~AcA~TT~6TT~C~TAA~A~TCAA~AACT~6AAA~A~A~A6~AA~ATAA 
2368  A6AAT~AATC~CM~T~TT~TTTTAAT~TTAT6~CAATACTTT~AACTTAAAAACA~A~TAAA6AA~T66TTCTAAAATTACAC6TA~TAAA66~ATTAMTACTACMATTCATTC[CA 
2488  ATCATCACTATCACCTTGGCTCAAAACAACTCT  2520 
Figure  2.  The sequence of SEC2.  These sequence data are available from EMBL/GenBank/DDBJ  under  accession number x52147. 
vivo or during preparation of the lysates, leading to complete 
conversion of the  105-kD protein  to the  shortened  forms. 
The mutant alleles could alternatively encode proteins trun- 
cated by deletion or by nonsense codons. If the reduced mo- 
lecular mass is the result of a premature stop codon, then in- 
troduction  of an  appropriate  nonsense  codon  suppressor 
tRNA  should  alleviate  the  temperatures-sensitive  growth 
defects of these mutants by facilitating the production of full 
length See2 protein. Dr. Ian Willis and Dr. Dieter $611 (the 
Molecular Biophysics and Biochemistry department of Yale 
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Figure 3. (,4) Comparison  of Sec2 pro- 
tein  with  $2 region of cardiac  muscle 
myosin  ot  heavy  chain.  The  top  line 
shows the sequence of the amino termi- 
nus of Sec2. The line below is a portion 
of the $2 region of rabbit cardiac muscle 
a-myosin heavy  chain  as  reported  by 
Kavinsky et al., 1984. Double dots indi- 
cate identity; single dots indicate a con- 
served change. This comparison  repre- 
sents the optimized lineup as performed 
by the program of Lipman and Pearson, 
1985. (B) Helical wheel portrayal of the 
region of Sec2  from amino  acids  50- 
106. The hydrophobic amino acids are 
shadowed and the charged amino acids 
are indicated.  Possible salt bridges are 
shown by the light lines. 
University)  generously  donated  three  plasmids,  renamed 
pNB305, pNB306, and pNB307, each containing a gene en- 
coding a suppressor tRNA for one of the three stop codons: 
opal  (UGA),  amber (UAG),  and  ochre (UAA).  The  three 
genes sup9e (opal), supS1 (amber), and SUQ5 (ochre), from 
either Saccharomyces pombe or Saccharomyces cerevisiae, 
were placed into the YCp50 shuttle vector. NY26 (sec2-59, 
ura3-52) and NY130 (sec2-41, ura3-52) strains were trans- 
formed,  separately,  with  each  of the  three  plasmids,  and 
transformants were selected on SD medium at 25°C.  After 
3  d,  transformants  were  stamped  to  YPD  plates  and  in- 
cubated at 30°C, 36°C, and 37°C overnight. Of the six new 
strains  (NY692-NY697),  only the  two carrying the  sup9e 
opal suppressor gene,  NY692  (sec2-59) and NY693  (sec2- 
41 ), grew at the restrictive temperatures (data not shown). 
The  sup9e  gene more effectively suppressed sec2-41  than 
sec2-59. Suppression ofsec2-41 by sup9e was equally strong 
at all three temperatures whereas suppression of sec2-59 was 
strong at 30°C  but weak at 37°C.  Immunoblots reveal the 
production of a small amount of the full length,  105-kD Sec2 
protein in the sup9e containing strains but not in those carry- 
ing the supS1  and SUQ5 genes (Fig.  5).  In addition,  more 
105-kD protein  is  present  in  the sec2-41  strain  (NY693), 
which is well suppressed than in the sec2-59 strain (NY692), 
which is suppressed more weakly. 
The efficiency of suppression was determined by a quan- 
titative evaluation of invertase secretion in the mutant strains 
Figure 4.  Anti-Sec2 immunoblot analysis of various sec2 alleles. 
(Lanes I and 2) NY 567, a strain carrying the SEC2 gene on a mul- 
ticopy plasmid. Lane 1 was loaded with one-tenth as much protein 
as the other lanes on the gel. (Lane 3) NY 15, a wild-type strain; 
(lane 4) NY130, a sec2-41 strain; (lane 5) NY26, a sec-59 strain; (lane 
6) NY673, a sec2-70 strain; (lane 7) NY701, a diploid strain carry- 
ing one wild-type SEC2 allele and one sec2-71 allele. 
Figure 5. Anti-Sec2 immunoblot ofsec2-41 and sec2-59 strains car- 
rying tRNA suppressors.  (Lane 1) Nyl5, a wild-type strain; (lane 
2) NYI30, a sec2-41 strain; (lane 3) NY26, a sec2-59 strain; (lane 
4) NY692, a sec2-59 strain containing the Sup9e tRNA suppres- 
sor;  (lane 5) NY693, a sec2-41 strain containing  the Sup9e sup- 
pressor;  (lane  6)  NY694, a sec2-59 strain  containing  the SupSl 
suppressor;  (lane  7) a sec2-41 strain  containing  the SupS1 sup- 
pressor; (lane 8) NY696, a sec2-59 strain containing the S UQ5 sup- 
pressor; (lane 9) NY697, a sec2-41 strain containing the SUQ5 sup- 
pressor. 
Nab et al. Sec2 Protein  1903 Table IlL Suppression of  sec2 Secretion Defect 
by tRNA Suppressors at 37~C 
Invertase Activity 
(#M glucose/min-A600U) 
External  Internal  Invertase 
Strain  sec  Suppressor  0 h  1 h  0 h  1 h  secretion  (%) 
NY 13  SEC2  -  .013  .250 .044 .050  98 
NY 26  sec2-59  -  .014  .024 .033  .624  2 
NY 130  sec2-41  -  .016  .036 .033  .496  4 
NY 692  sec2-59  sup9-e  .014 .231  .037 .181  60 
NY 693  sec2-41  sup9-e  .013 .232 .036 .127  71 
NY 694  sec2-59  supS1  .018  .025 .037 .599  1 
NY 695  sec2-41  supS1  .015  .031  .037 .498  2 
NY 696  sec2-59  SUQ5  .015  .018 .035 .550  1 
NY 697  sec2-41  SUQ5  .015  .028 .036 .461  3 
NY 673  sec2-70  -  .013  .154 .037 .053  90 
carrying the suppressor tRNA plasmids. Cultures of the rele- 
vant strains were grown overnight at 25°C in media contain- 
ing 2% glucose to repress synthesis of invertase. Cells (2.0 
Am U) were pelleted, resuspended in low glucose to dere- 
press invertase production, and incubated 1 h at 37°C. Intra- 
cellular and external invertase activity were then measured. 
The percentage of invertase secreted is a measure of the se- 
cretion block.  As illustrated in Table III, wild-type strains 
secrete at levels near 100% while the mutant strains, NY26 
and NY130, release only a very small amount of the invertase 
produced.  The presence of either amber or ochre suppres- 
sors does not affect the levels of invertase secreted from the 
mutants:  However, when the sup9e gene is introduced,  se- 
cretion of invertase increases dramatically, rising to 60 % in 
the sec2-59 strain and to 71%  in the sec2-41  strain. 
The efficiency of suppression of the vesicle accumulation 
phenotype of the mutant alleles was evaluated by thin section 
electron microscopy (Fig. 6, A-D). As has been previously 
demonstrated,  sec2-41  accumulates  secretory  vesicles  at 
37°C.  The same strain carrying an opal tRNA  suppressor 
(NY693, Fig. 6 C) does not accumulate vesicles at this tem- 
perature, while a strain carrying an amber tRNA suppressor 
(NY 695,  Fig.  6 D) still  shows the mutant phenotype. 
Sequence of  sec2-59 
Final  proof of the identity of the sec2-59 allele lies in the 
nucleotide  sequence.  To accomplish the sequencing of the 
mutant, the allele was cloned using a technique described by 
Saliminen and Novick (1987). The plasmid pNBI32 was di- 
gested with Xba I, generating linearized molecules "gapped" 
over the entire SEC2 coding region but leaving the flanking 
sequences intact.  These gapped plasmids were introduced 
into the NY26 strain. The chromosomal sequences repair the 
gapped regions of the plasmid. The plasmid, reisolated from 
yeast and purified through E. coli contains the sec2-59 gene. 
Sequence analysis of the sec2-59 gene, cloned on the plasmid 
pNB303,  confirmed that the mutation is a  premature opal 
stop codon. At 1,125 bp in the coding sequence, a point muta- 
tion occurs, a change from a guanine to an adenine residue, 
and the resulting codon (1,123-1,125  bp) in the SEC20RF 
is a  UGA opal stop codon (Fig.  2).  The sec2-59 sequence 
predicts a protein of 374 amino acids and an estimated mo- 
lecular mass of 41.1 kD, consistent with the band observed 
on immunoblots (Fig. 4). 
SEC2 Is an Essential Locus; However, Truncated Sec2 
Proteins Are Still Functional 
Two models can account for the temperature-sensitivity of 
the se2-41  and sec2-59 strains. Either Sec2 function is only 
required  at elevated temperatures or  Sec2  function  is  re- 
quired at all temperatures, and the carboxy terminal half of 
the protein is only necessary at elevated temperatures. To test 
these possibilities, we constructed an allele, sec2-72, which 
lacked the region immediately upstream of the protein start 
as well as the amino terminal coding region. This construc- 
tion replaced the Pvu II-Nsi I region of SEC2 with the URA3 
gene (Fig.  1 C). This allele was introduced into the genome 
by the one step gene disruption technique (Rothstein,  1983) 
so as to replace one copy of SEC2 in a diploid strain, NY363. 
Three Ura  ÷ transformants were sporulated and subjected to 
tetrad analysis at 25°C. All 30 tetrads analyzed yielded two 
viable and  two  inviable spores.  No viable Ura  ÷ were ob- 
tained.  The  inviable  spores  successfully germinated,  and 
gave rise to microcolonies of  4-8 cells before division ceased. 
Therefore, SEC2 is required for vegetative growth at 25°C 
as well as at elevated temperature. This result also implies 
that the sec2-41 and sec2-59 alleles do encode partially func- 
tional Sec2 protein despite the truncation of up to 50%  of 
the protein sequence. 
To map the regions of the protein necessary for growth at 
different temperatures two additional alleles of SEC2 were 
generated by truncation of the C-terminus. For construction 
of the first allele, an internal Rsa I-Ava II fragment, extend- 
ing from 625-1,524 bp of the coding sequence, was inserted 
into the YIp5 vector to create the plasmid pNB289  (Table 
II and Fig.  1, B and C). Transformants were selected on min- 
imal medium at 25°C. Directed integration at the SEC2 locus 
of the haploid  wild-type strain  NY15  (ura3-52,  his4-619) 
transformed with pNB289 linearized by Xba I digestion cre- 
ates a duplication in which both copies ofsec2 are truncated, 
one at the amino terminus, the other at the carboxy terminus 
(Fig.  1 C, line 2).  With  neither an AUG codon nor a pro- 
moter sequence, the amino terminal truncation cannot serve 
as a template for transcription. Therefore, the only Sec2 pro- 
tein produced in this transformed strain (NY673) originates 
from the carboxy terminal truncated gene, designated sec2- 
70, encoding a protein of 519 amino acids, 508 from SEC2 
Figure 6. Thin section analysis ofsec2-41  with suppressor plasmids. (A) NYI3, a wild-type strain incubated at 37°C for 1 h. (B) NY130, 
a sec2-41 strain incubated at 37°C for 1 h. (C) NY693, a sec2-41 strain carrying the Sup9e suppressor  incubated at 37°C for 1 h. (D) 
NY695, a sec2-41 strain carrying the SupSl  suppressor  incubated at 37°C for 1 h.  (E) NYI30,  a sec2-41 strain  incubated at 34°C for 
1 h.  (F) NY723, a sec2-41 strain carrying an episomal copy of SEC4 incubated at 34°C for 1 h. 
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by SEC4 0verexpression at 34°C 
lnvertase Activity 
(#M glucose/min.As~oU) 
Suppressor  External  Internal  Invertase 
Strain  sec  plasmid  0 h  I h  0 h  1 h  secretion  (%) 
NY  13  SEC2  -  .016  .402 .051  .055  99 
NY 718  SEC2  pNB 139  .022 .271  .047 .051  98 
NY 719  SEC2  pNB 170  .028 .307 .046 .054  97 
NY 26  sec2-59  -  .030  .237 .039  .348  40 
NY 720  sec2-59 pNB 139  .021  .369 .040  .237  64 
NY721  sec2-59 pNB 170  .021  .375 .043  .139  79 
NY  130  sec2-41  -  .025  .329 .038  .317  52 
NY 722  sec2-41  pNB 139  .024 .325 .041  .127  78 
NY 723  sec2-41  pNB 170  .018 .356 .039 .113  82 
sequence and 11 from read through into the adjacent pBR322- 
derived vector region, as determined from insert orientation 
and examination of SEC2 and vector sequences.  This pro- 
tein, missing the last 251 amino acids of the SEC2 gene prod- 
uct,  migrates at 58  kD on immunoblots of NY673  lysates 
(Fig. 4), as expected from its sequence.  More importantly, 
NY673  exhibits  no  temperature-sensitive defect,  growing 
normally at 37°C. As expected from its good growth, sec2- 
70 shows only slight decrease in secretion, down to 90% (Ta- 
ble III), confirming that removal of the last 251 amino acids 
does not create a  temperature-sensitive allele of SEC2. 
As removal of the last 251 amino acids did not create a con- 
ditional  lethal  defect,  we  constructed  a  second  allele  in 
which a greater portion of the protein was deleted. An 0.867- 
kb Sau IIIA-Sau IIIA fragment, extending from 306 to 1,173 
bp, was inserted into YIp5. This plasmid, pNB298, was lin- 
earized at the  internal  Xba I  site and used to transform a 
haploid strain (NY15) and a diploid strain (NY363). As be- 
fore, transformants were selected on SD medium at 25°C. 
Homologous recombination produced a gene duplication in 
which the carboxy terminal deletion, sec2-71, lacks the last 
368 amino acids of the Sec2 protein (Fig. 1 C, line 3). In this 
instance,  the haploid transformants (NY688)  exhibited  se- 
verely  restricted  growth  at  25°C,  and  at  37°C  the  allele 
proved lethal.  On immunoblots of lysates from the diploid 
transformant (NY701), anti-Sec2 antisera recognized a 46- 
kD band (Fig. 4), as expected for the 429 amino acid protein 
encoded by the sec2-71 gene: SEC2 contributes 391  amino 
acids, and the final 38 residues originate from read through 
into the vector, as determined by analysis of the insert orien- 
tation  and  the  insert  and  vector  sequences.  Because  the 
haploid sec2-71  strain,  NY688,  is nearly inviable at 25°C, 
immunoblot and secretion analysis was not performed. 
Although  sec2-71  encodes  a  protein  that  is  somewhat 
longer (391  amino acids of Sec2) than that encoded by sec2- 
59 (374 amino acids),  the sec2-71  mutation causes a  more 
severe growth defect at 25°C than does the sec2-59 mutation. 
There are several possible explanations for this finding. Im- 
munoblot analysis (Fig. 4) suggests that the sec2-71 mutation 
not only truncates the protein but also lowers the level of ex- 
pression. Thus, the combined effects of truncation and low- 
ered  expression  may  be  more  severe  than  the  somewhat 
greater truncation resulting from the sec2-59 mutation. An- 
other possibility is that the 38 amino acids at the carboxy ter- 
minus that result from read through into vector sequence im- 
pede function of the sec2-71 protein.  Finally, there may be 
a low level of full-length Sec2 protein made in the sec2-59 
strain as a  consequence of occasional read through of the 
opal codon.  This low level of full length protein could en- 
hance the growth rate at 25°C, but still be insufficient to sus- 
tain the growth at 37°C. No evidence for any full length pro- 
tein can be seen by immunoblot analysis (Fig. 4); however, 
sensitivity of detection may be limiting. 
Duplication of SEC4 Suppresses the Secretion 
Block in sec2-41 or sec2-59, but Does Not Alter the 
Expression of the Mutant Protein or Suppress 
a sec2 Null Mutation 
In a previous report, we demonstrated that duplication of the 
SEC4 gene could partially suppress the growth defect result- 
ing from the sec2-41 mutation (Salminen and Novick, 1987). 
We have investigated the nature of this phenomenon in greater 
detail.  Two different plasmids were  introduced  into  wild- 
type and sec2 mutant strains: pNB139 yields approximately 
normal  expression  of SEC4  thereby  duplicating  the  total 
Sec4 protein level, while pNB170 yields severalfold higher 
than normal expression (Walworth et al.,  1989).  At 34°C 
both sec2-41 and sec2-59 exhibit a partial block in invertase 
secretion  (Table  IV).  Introduction  of  either  pNB139  or 
pNB170 allows increased efficiency of secretion.  A  some- 
what greater effect is seen with pNB170 than with pNB139, 
as is consistent with the higher level of Sec4 protein expres- 
sion.  Thin-section  electron  microscopy demonstrated  that 
pNB170 suppressed the vesicle accumulation phenotype of 
sec2-41 at 34°C (Fig. 6, E and F). These results indicate that 
increased expression of SEC4 suppresses the growth defect 
of sec2 mutants by suppressing the  secretory block rather 
than by allowing the cells to tolerate the secretory block. 
Suppression of sec2 mutations by increased expression of 
SEC4  could  be  the  result  of increased  expression  or  in- 
creased stability of the sec2 mutant protein. To test this pos- 
sibility, lysates were prepared from sec2 mutants with and 
without plasmids carrying an extra copy of SEC4.  Fig.  7 
demonstrates that there is no detectable change in the level 
Figure  7.  Anti-Sec2 immunoblot  of sec2-41  and sec2-59  strains 
with and without an extra copy of SEC4. (Lane 1) NY 15, a wild- 
type strain.  (Lane 2) NY26, a sec2-59 strain.  (Lane 3) NY721, a 
sec2-59 strain carrying an episomal copy of SEC4. (Lane 4) NYI30, 
a sec2-41 strain.  (Lane  5) NY723,  a sec2-41 strain  carrying  an 
episomal copy of SEC4. 
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Double sec Mutants 
sec  (sec,  sec2-41) 
25°C  30°C  33.5°C  37°C  25°C  30°C  33.5°C  37°C 
secl-1  +  +  -  -  +  - 
sec2-41  +  +/-  -  - 
sec3-2*  +  +  +  -  /  +  -  - 
sec4-8*  +  +  -  /  +  -  -  - 
sec5-24"  +  +  -  /  +  -  -  - 
sec6-4  +  +  -  -  +  /  -  - 
sec7-1  +  +  +  -  +  -/+ 
sec8-9*  +  +  +  -  -  - 
sec9-4  +  +/-  -  -  +/-  - 
seclO-2*  +  +  +  -  -  - 
secl2-4  +  +/-  -  -  +  - 
secl3-1  +  +/-  -  -  +  - 
secl4-3  +  +  +  -  +  +/- 
secl5-1*  +  +  +  -/+  -  - 
secl6-2  +  -/+  -  -  +  -/+ 
seclT-I  +  +  +/-  -  +  +/- 
secl8-1  +  -  -  -  +  - 
secl9-1  +  +  -  /+  - 
sec20-1  +  +/-  -  -  +  +/- 
sec21-1  +  +  +  -  +  +/'-- 
sec22-3  +  +/-  -  -  +  +/- 
sec23-1  +  +/-  -  -  +  -/+ 
m  m 
_  B 
m 
m  m 
m  m 
_  i 
m 
_  D 
_  m 
*Crosses in which the double mutants were inviable. 
of the Sec2 mutant protein as a result of SEC4 overexpres- 
sion. This result indicates that stabilization or increased ex- 
pression of Sec2 protein is not the basis of the observed sup- 
pression by Sec4 overproduction. 
Suppression of sec2 mutations by overexpression of SEC4 
could also be the result of a bypass of Sec2 protein function. 
This mechanism should allow suppression of a null allele. To 
test this possibility one of the SEC2 genes in a ura3-52/ura3- 
52,  leu2-3,112/leu2-3,112 diploid strain was disrupted with 
the URA3 gene (Fig.  1 C, bottom line). The resulting sec2- 
72/SEC2 strain was subsequently transformed with a  plas- 
mid carrying the LEU2 and SEC4 genes (pNB318, Table II) 
by directing integration into the SEC4 locus. This strain, car- 
rying one duplicated copy of SEC4 and one disrupted copy 
of SEC2, was subjected to tetrad analysis and spores were 
allowed to germinate at both 25°C and  14°C.  If duplication 
of SEC4 could suppress a sec2 null allele then some tetrads 
should have contained three or four viable spores including 
one  or  two  Ura  ÷,  Leu  ÷ products.  This  was  not  seen.  All 
tetrads contained only two viable spores, none of which were 
Ura  ÷, although many were Leu  ÷. This result establishes the 
fact that duplication of SEC4 cannot suppress a null allele of 
sec2,  ruling out the bypass mechanism of suppression, and 
furthermore implies that suppression of sec2-41 requires the 
residual activity of the truncated protein at the elevated tem- 
perature. 
sec-41 Is Lethal in Combination with a Subset of Late 
sec Mutants 
In a previous study, we showed that sec4-8 could not be com- 
bined in a haploid strain with mutations in any of a set ofsec 
genes (Salminen and Novick, 1987). This set consisted of six 
of the nine other sec genes whose products are required for 
post-Golgi events, and it includes the SEC2 gene. To extend 
this study we crossed a sec2-41 strain to strains containing 
mutations in each of the late-acting SEC genes. The diploids 
were sporulated, tetrads were dissected, and allowed to ger- 
minate at 25°C.  Lethality of about one quarter of the spores 
was seen in six crosses (Table V)..The viable spores were 
tested for temperature-sensitivity. The pattern of inviability 
and temperature-sensitivity was consistent with the hypothe- 
sis that the double mutants are inviable in these cases. When 
all four spores were viable, they were all temperature-sensi- 
tive; when three were viable, two were temperature-sensi- 
tive, and when two were viable, they were both temperature- 
resistant.  The lethal combinations are sec2-41 with sec3-2, 
sec4-8, sec5-25, sec8-9, seclO-2, or sec15d. The same set of 
mutations that are lethal when combined with sec2-41 were 
previously found  to  be  lethal  when  combined with  either 
sec4-8 and sec15-1 (Salminen and Novick,  1987).  The only 
exception is sec19-1. This mutation is inviable in combina- 
tion  with  sec4-8,  but  viable  in  combination  with  secl5-1 
(Salminen and Novick, 1987).  Combination of secl9-1 with 
sec2-41 results  in  viable colonies  at 25°C;  however, their 
growth is severely restricted. 
Sec2 Protein Is Present in a Soluble, High Molecular 
Mass Complex 
If, as predicted by its sequence, Sec2 protein interacts with 
itself or with another polypeptide, then it should display a 
native molecular mass significantly higher than that of the 
SDS-denatured protein. To test this possibility, a lysate was 
prepared by osmotic lysis of yeast spheroplasts  and  frac- 
tionated by the scheme described in Goud et al.,  1988.  The 
unbroken cells were cleared by centrifugation at 450 g  for 
5 min. This lysate was then spun at 10,000 g for 10 min, and 
the supernatant of that spin was spun at  100,000 g  for 1 h. 
Immunoblot analysis of the supernatant and pellet fractions 
indicated that 6% of the total Sec2 protein (total is defined 
as that present in the 450 g  supernatant)  was pelletable at 
10,000 g, 9% was pelletable at 100,000 g, and 50% was solu- 
ble (Fig. 8). This soluble fraction was applied to a Sephacryl 
S 300 HR (Pharmacia Fine Chemicals, Piscataway, N  J) col- 
umn and eluted in 20 mM Hepes (pH 7.5),  50 mM NaC1, 
Figure 8. Solubility properties of Sec2 protein. Anti-Sec2 immuno- 
blot analysis of samples derived from differential centrifugation of 
a wild-type (NYI3) lysate. (Lane 1) 450 g supernatant.  (Lane 2) 
10,000 g pellet. (Lane 3) 10,000 g supernatant.  (Lane 4) 100,000 g 
pellet.  (Lane 5)  100,000 g supernatant. 
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by immunoblot analysis and compared to the elution pattern 
of molecular mass standards (data not shown). A native mo- 
lecular mass of "0500-750 kD was established. Analysis of 
a Sec2-41 lysate was attempted; however, the truncated pro- 
tein was apparently unstable and no molecular mass determi- 
nation could be made. 
Discussion 
We have presented an analysis of SEC2 and its protein prod- 
uct. A major finding from these studies is that the Sec2 pro- 
tein can be viewed as having two domains. The amino termi- 
nal  half of the protein is essential and contains a peptide 
sequence that is predicted to be in an c~-helical, coiled-coil 
conformation, while the carboxy terminal half of the protein 
is  largely dispensable  at  25°C.  We have also  probed the 
mechanism by which overproduction of Sec4 protein yields 
suppression of sec2 mutants. 
During the initial  isolation of secretory mutants,  muta- 
tions in the sec2 gene were greatly overrepresented. Of 190 
mutants that were defective in posttranslational events of the 
secretory pathway, 69 were found to be defective in the sec2 
gene,  while the  remaining  mutants  defined 22  additional 
complementation groups (Novick et al.,  1980).  The reason 
for this overrepresentation is now clear. Any nonsense muta- 
tion that truncates the Sec2 protein in the appropriate region 
will  lead to a  temperature-sensitive secretory defect. The 
critical region of Sec2 appears to lie between amino acids 
374 and 391. This situation is in striking contrast to the SEC4 
gene, where three independently isolated mutations were all 
found to encode the same change of glycine at position 147 
to aspartate, suggesting that the range of targets for this gene 
is much more restricted (Salminen and Novick, 1987; Wal- 
worth, unpublished data). 
Our finding that the carboxy terminal half of Sec2 is dis- 
pensable has allowed us to focus more intensively on the 
amino terminal half of the protein for clues to the function 
of Sec2. Homology searches revealed significant similarity 
of this region of Sec2 to a number of cytoskeletal proteins 
including myosin and tropomyosin. Since previous studies 
have suggested a  role for the actin based cytoskeleton in 
vesicular transport at the post-Golgi apparatus stage of the 
yeast secretory pathway (Novick and Botstein,  1985), one 
could postulate that Sec2 interacts with the cytoskeleton to 
facilitate vesicle transport. However, we believe that the se- 
quence similarity of Sec2  with  cytoskeletal proteins may 
simply reflect the fact that this region of Sec2, like many 
cytoskeletal proteins, exists as a coiled-coil a-helix, and it 
does not necessarily imply that Sec2 is itself cytoskeletal in 
nature. Supporting our hypothesis that Sec2 is complexed ei- 
ther with itself or with other components, we find that it has 
a very large apparent native molecular mass. Although Sec2 
is predominantly soluble under the conditions tested, further 
studies will be needed to determine if the Sec2 complex is 
normally associated with a subcellular structure such as the 
cytoskeleton or an organelle. 
The studies presented here allow a sharper definition of the 
interactions between SEC2 and some of the other late acting 
SEC genes. Previous work has shown that duplication of the 
SEC4 gene will suppress the growth defect of the tempera- 
ture-sensitive sec2-41 allele (Salminen and Novick,  1987). 
We now show that overexpression of SEC4 will partially sup- 
press all of the defects of sec2-41, and yet will not suppress 
a disruption of SEC2. Furthermore, overexpression of SEC4 
does not result in overexpression or stabilization of the mu- 
tant sec2-41 gene product. These results are most consistent 
with a model in which the Sec4 protein acts as an upstream 
activator of Sec2 protein function. Sec4 was also invoked as 
an upstream activator of Secl5 protein function to explain 
similar data regarding the suppression of the sec15-I muta- 
tion  by  overexpression of SEC4 (Salminen  and  Novick, 
1989).  A number of other genes may also be involved in this 
functional interaction.  Mutations  in sec2,  sec4,  and secl5 
exhibit synthetic lethality with each other, and in each case 
they also show synthetic lethality with mutations  in sec3, 
sec5, sec8, and seclO. 
The physical basis for the observed genetic interactions is 
not yet clear. Biochemical studies suggest that components 
must exist to regulate both the exchange of GTP onto Sec4 
as well as to stimulate hydrolysis of the bound nucleotide 
(Kabcenell et al.,  1990).  Several of the  interacting genes 
may encode such elements and biochemical analysis of the 
mutant strains may reveal these relationships. The enzymatic 
cycle of GTP binding and hydrolysis may be coupled to a 
topological cycle of Sec4 attachment to vesicles, exocytotic 
fusion, and recycling of Sec4 to new vesicles (Goud et al., 
1988; Bourne, 1988; Walworth et al., 1989). By this model, 
vesicular Sec4 serves to direct the association of vesicles 
with the plasma membrane. This docking event may require 
the assembly of a complex of additional components. Hy- 
drolysis of the bound GTP would allow disassembly of the 
complex for reutilization.  The products of the interacting 
genes are candidates for components that act in response to 
Sec4 to control the interaction of vesicles with the plasma 
membrane. Overproduction of Sec4 may increase its concen- 
tration on the vesicle surface and by recruiting additional 
components to the docking complex help to overcome a par- 
tial defect in one of these downstream elements.  Further 
studies on the interaction of these proteins with one another 
and with the compartments of the secretory pathway will al- 
low us to test these proposals. 
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